Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Avinash Undale"'
Autor:
Dilip Kumar, Sourav Singha Roy, Ruchir Rastogi, Kajal Arora, Avinash Undale, Reeshu Gupta, Nupur Mehrotra Arora, Prabuddha K. Kundu
Publikováno v:
Vaccines, Vol 11, Iss 4, p 743 (2023)
Background: Serological methods to conduct epidemiological survey are often directed only against the spike protein. To overcome this limitation, we have designed PRAK-03202, a virus-like particle (VLP), by inserting three antigens (Spike, envelope a
Externí odkaz:
https://doaj.org/article/84b33d3a8bbd4fc496b8745cea88f156
Autor:
Saumyabrata Mazumder, Ruchir Rastogi, Avinash Undale, Kajal Arora, Nupur Mehrotra Arora, Biswa Pratim, Dilip Kumar, Abyson Joseph, Bhupesh Mali, Vidya Bhushan Arya, Sriganesh Kalyanaraman, Abhishek Mukherjee, Aditi Gupta, Swaroop Potdar, Sourav Singha Roy, Deepak Parashar, Jeny Paliwal, Sudhir Kumar Singh, Aelia Naqvi, Apoorva Srivastava, Manglesh Kumar Singh, Devanand Kumar, Sarthi Bansal, Satabdi Rautray, Manish Saini, Kshipra Jain, Reeshu Gupta, Prabuddha Kumar Kundu
Publikováno v:
Heliyon, Vol 7, Iss 10, Pp e08124- (2021)
The rapid development of safe and effective vaccines against severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) is a necessary response to coronavirus outbreak. Here, we developed PRAK-03202, the world's first triple antigen virus-like part
Externí odkaz:
https://doaj.org/article/0dfd59dfde2d410a8ba0a7733014be0b
Autor:
Saumyabrata Mazumder, Ruchir Rastogi, Avinash Undale, Kajal Arora, Nupur Mehrotra Arora, Biswa Pratim, Dilip Kumar, Abyson Joseph, Bhupesh Mali, Vidya Bhushan Arya, Sriganesh Kalyanaraman, Abhishek Mukherjee, Aditi Gupta, Swaroop Potdar, Sourav Singha Roy, Deepak Parashar, Jeny Paliwal, Sudhir Kumar Singh, Aelia Naqvi, Apoorva Srivastava, Manglesh Kumar Singh, Devanand Kumar, Sarthi Bansal, Satabdi Rautray, Manish Saini, Kshipra Jain, Reeshu Gupta, Prabuddha Kumar Kundu
Publikováno v:
Heliyon, Vol 7, Iss 10, Pp e08201- (2021)
Externí odkaz:
https://doaj.org/article/117420d8026e444fbb9e9805bd44c6ef
Autor:
Aelia Naqvi, Kajal Arora, Ruchir Rastogi, Jeny Paliwal, Apoorva Srivastava, Sriganesh Kalyanaraman, Deepak Parashar, Manish Saini, Prabuddha Kumar Kundu, Nupur Mehrotra Arora, Sudhir Kumar Singh, D. Kumar, Bhupesh Mali, Manglesh Kumar Singh, Vidya Bhushan Arya, Biswa Pratim, Abhishek Mukherjee, Avinash Undale, Swaroop Potdar, Saumyabrata Mazumder, Dilip Kumar, Sarthi Bansal, Aditi Gupta, Sourav Roy, Abyson Joseph, R. S. Gupta, Satabdi Rautray, Kshipra Jain
Publikováno v:
Heliyon, Vol 7, Iss 10, Pp e08201-(2021)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffcbe2a75c7d3cfd8088883b2afa4bea
http://www.sciencedirect.com/science/article/pii/S2405844021023045
http://www.sciencedirect.com/science/article/pii/S2405844021023045
Autor:
Sriganesh Kalyanaraman, Biswa Pratim Das Purkayastha, Kajal Arora, Nupur Mehrotra Arora, Manish Saini, Apoorva Srivastava, Manglesh Kumar Singh, Aditi Gupta, Prabuddha Kumar Kundu, Sourav Roy, Avinash Undale, Saumyabrata Mazumder, D. Kumar, Swaroop Potdar, Dilip Kumar, Bhupesh Mali, Jeny Paliwal, Bivekanand Kumar, Aelia Naqvi, Abyson Joseph, R. S. Gupta, Satabdi Rautray, Abhishek Mukherjee, Indrajeet Singh, Kshipra Jain, Sarthi Bansal, Ruchir Rastogi, Sudhir Kumar Singh, Pankaj Surendra Fengade, Vidya Bhushan Arya, Deepak Parashar
The rapid development of safe and effective vaccines against SARS CoV-2 is the need of the hour for the coronavirus outbreak. Here, we have developed PRAK-03202, the world’s first triple antigen VLP vaccine candidate in a highly characterized S. ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::018355b6c840ffeb33de7fbf4324655d
https://doi.org/10.1101/2020.10.30.360115
https://doi.org/10.1101/2020.10.30.360115
Autor:
Jeny Paliwal, Prabuddha Kumar Kundu, Dilip Kumar, Sriganesh Kalyanaraman, Sourav Singha Roy, Nupur Mehrotra Arora, Ruchir Rastogi, Manish Saini, Biswa Pratim, Saumyabrata Mazumder, Abyson Joseph, Avinash Undale, Swaroop Potdar, Kajal Arora, D. Kumar, Apoorva Srivastava, Sarthi Bansal, Kshipra Jain, Satabdi Rautray, Manglesh Kumar Singh, Vidya Bhushan Arya, R. S. Gupta, Sudhir Kumar Singh, Aditi Gupta, Bhupesh Mali, Deepak Parashar, Aelia Naqvi, Abhishek Mukherjee
Publikováno v:
Heliyon
Heliyon, Vol 7, Iss 10, Pp e08124-(2021)
Heliyon, Vol 7, Iss 10, Pp e08124-(2021)
The rapid development of safe and effective vaccines against severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) is a necessary response to coronavirus outbreak. Here, we developed PRAK-03202, the world's first triple antigen virus-like part
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7280c89934efe46019adb8e0223003fd
https://doi.org/10.1016/j.heliyon.2021.e08124
https://doi.org/10.1016/j.heliyon.2021.e08124